Alimta® (Pemetrexed)

Para consultar la información para prescribir completa de Alimta® (Pemetrexed) de clic en el siguiente enlace: Información para prescribir

La información es proporcionada en respuesta a su solicitud, y puede contener datos relacionados a dosis, usos, formulaciones y poblaciones diferentes a la Información para Prescribir del producto. Consulte la Información para Prescribir en la liga que aparece arriba.

Pemetrexed: Vitamin Supplementation

Prior to pemetrexed treatment, initiate vitamin supplementation consisting of oral folic acid and IM vitamin B12 to reduce severity of pemetrexed toxicity.

MX_cFAQ_PEM050_VITAMIN_SUPPLEMENTATION
MX_cFAQ_PEM050_VITAMIN_SUPPLEMENTATION
es-MX

Detailed Information

The information contained in this letter may not completely match the current local labeling for PEMETREXED. Please see local labeling approved in your country.

To reduce toxicity, patients treated with pemetrexed must be instructed to take a folic acid preparation or a multivitamin with folic acid

  • as a daily oral low-dose
  • initiated during the 7-day period preceding the first dose of pemetrexed, and for at least 5 doses, and
  • during the full course of therapy and for 21 days after the last dose of pemetrexed.1

In clinical trials, the dose of folic acid studied ranged from 350 to 1000 μg. The most commonly used dose of oral folic acid in clinical trials was 400 μg.1

Patients must also receive vitamin B12

  • as an IM injection
  • initiated the week preceding the first dose of pemetrexed, and
  • every 3 cycles thereafter.1

Subsequent vitamin B12 injections may be given the same day as pemetrexed.1 In clinical trials, the dose of vitamin B12 received was 1000 μg.

Effects of Vitamin Supplementation on Toxicity

In the phase 3 MPM registration trial, pretreatment with folic acid and vitamin B12 led to overall less toxicity and reduction in grade 3/4 hematologic and nonhematologic toxicities such as

  • neutropenia
  • febrile neutropenia, and
  • infection with grade 3/4 neutropenia.1,2

Therefore, patients treated with pemetrexed must be instructed to take folic acid and vitamin B12 as a prophylactic measure to reduce treatment-related toxicity.1

Effects of Vitamin Supplementation on Pharmacokinetics

The PK of pemetrexed are not influenced by oral folic acid and IM vitamin B12 supplementation.1

References

1Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636-2644. https://doi.org/10.1200/JCO.2003.11.136

Glossary

IM = intramuscular

MPM = malignant pleural mesothelioma

PK = pharmacokinetic(s)

Fecha de la última revisión: 2021 M05 27


Contáctenos para saber más de la información Médica de Lilly

Contacto vía correo electrónico

Correo electrónico: infomed@lilly.com

Envíe su consulta

Escriba su consulta